AA
CHE icon

AlphaCentric Advisors’s Chemed CHE Stock Holding History

AlphaCentric Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$520K Buy
+982
New +$554K 0.52% 53

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaCentric Advisors's CHE Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in Chemed (CHE) in Q4 2024: 982 shares worth $520K. The stake represents 0.52% of the portfolio and ranks #53 among its holdings.

528 funds tracked by Wall St. Rank hold CHE as of Q4 2024.

  • AlphaCentric Advisors held 982 shares of Chemed worth $520K as of Q4 2024.
  • Chemed was a new AlphaCentric Advisors position in Q4 2024.
  • Chemed made up 0.52% of AlphaCentric Advisors's portfolio in Q4 2024, its #53 holding.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.